Everything below concerns solid-phase synthesis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-11-23. Numbers and descriptions here follow the published literature rather than marketing material.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or chemically modified byproducts. Mass spectrometry confirms the expected molecular mass and can indicate acetylation state or sequence errors. Amino acid analysis and peptide mapping supply complementary sequence-level information, while endotoxin testing is relevant for preparations intended for cell or animal work. Purity figures reported by suppliers refer to the method used and are not directly comparable across laboratories unless conditions are stated.
Lyophilized material is typically treated as a hygroscopic solid that should be brought to room temperature before the container is opened, which limits condensation on the powder. Reconstitution is commonly done with sterile water or a buffered diluent, and gentle mixing is preferred over vigorous agitation to reduce foaming and surface adsorption. Because peptides can bind to plastic and glass, diluents containing a small amount of carrier protein are sometimes used in laboratory work. Working solutions are generally aliquoted and prepared fresh rather than subjected to repeated freezing and thawing.
Stability depends on temperature, pH, and the number of freeze-thaw events the sample has experienced. Freeze-dried material is commonly held at -20 °C or colder, while reconstituted liquid is kept cold and used within a short window. Extreme pH and prolonged light exposure can promote deamidation, oxidation, or aggregation, particularly at asparagine and methionine positions. Adsorption to container walls can lower the measured concentration of a dilute solution even when the peptide molecules themselves remain intact.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Visual description varies by batch |
| Solubility | Freely soluble in water | Aqueous buffers are commonly used |
| Typical storage temperature | -20 °C or below for powder | Reconstituted liquid kept at 2-8 °C short term |
| Purity method | Reversed-phase HPLC | Value derived from peak area integration |
| Identity method | Mass spectrometry | Confirms mass and sequence integrity |
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
=== Legal status === In May 2022, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization under exceptional circumstances for the medicinal product Upstaza, intended for the treatment of aromatic L‑amino acid decarboxylase (AADC) deficiency. As Upstaza is an advanced therapy medicinal product, the CHMP positive opinion is based on an assessment by the Committee for Advanced Therapies. The applicant for this medicinal product is PTC Therapeutics International Limited. Eladocagene exuparvovec was approved for medical use in the European Union in July 2022. Eladocagene exuparvovec was approved for medical use in the United States in November 2024. The US Food and Drug Administration (FDA) granted the application for eladocagene exuparvovec priority review and orphan drug designations, and a rare pediatric disease priority review voucher. It was approved under the accelerated approval pathway. The FDA granted approval of Kebilidi to PTC Therapeutics.
== Veterinary use == Apomorphine is used to inducing vomiting in dogs after ingestion of various toxins or foreign bodies. It can be given subcutaneously, intramuscularly, intravenously, or, when a tablet is crushed, in the conjunctiva of the eye. The oral route is ineffective, as apomorphine cannot cross the blood–brain barrier fast enough, and blood levels don't reach a high enough concentration to stimulate the chemoreceptor trigger zone. It can remove around 40–60% of the contents in the stomach. One of the reasons apomorphine is a preferred drug is its reversibility: in cases of prolonged vomiting, the apomorphine can be reversed with dopamine antagonists like the phenothiazines (for example, acepromazine). Giving apomorphine after giving acepromazine, however, will no longer stimulate vomiting, because apomorphine's target receptors are already occupied. Apomorphine does not work in cats, who have too few dopamine receptors.
=== Biochemical activities === p200 CUX1 is a very abundant protein that binds to DNA with extremely fast kinetics (rapid "on" and "off" rates). This is not consistent with a role as a classical transcription factor that binds stably to DNA and recruits a co-activator or a co-repressor, however, the p200 CUX1 protein may still be able to repress transcription by competition for binding site occupancy. Indeed, CUX1 was originally purified as the CCAAT-displacement protein (CDP). In addition to this potential role in transcriptional repression, recent studies revealed that p200 CUX1 functions as an auxiliary factor in base excision repair. In vitro, CUT domains of CUX1 stimulate the enzymatic activities of the 8-oxoguanine DNA glycosylase (OGG1) and the apurinic/apyrimidinic endonuclease 1 (APE1). In agreement with results from in vitro DNA repair assays, a p200 CUX1-GFP fusion protein is rapidly recruited to DNA damage generated by laser microirradiation, while CUX1 knockdown in human cells causes a delay in the repair of oxidative DNA damage and mono-alkylated bases in genomic DNA, and sensitizes cancer cells to treatments with H2O2, ionizing radiation and the mono-alkylating agent temozolomide. Conversely, p200 CUX1 overexpression increases the resistance of cancer cells to the same treatments.
=== Fasegram === A Fasegraphy allows expanding the system of Electrocardiography diagnostic features, based on the evaluation of the speed characteristics of the process, and thereby increasing the sensitivity and specificity of ECG-diagnostics. Fasegraphy allows determining the initial features of changes in the cardiac muscle, even on a single-channel ECG, which are underestimated in traditional ECG diagnostics.
A section of the report pertaining to the internal functioning of the S&D Group was held over until September 2023 to allow for a discussion of its findings with the S&D Bureau prior to its publication.
Sources: en.wikipedia.org
=== DNA repair === Two classical DNA repair pathways, nucleotide excision repair and base excision repair, are present in hydra, and these repair pathways facilitate unhindered reproduction. The identification of these pathways in hydra is based, in part, on the presence in the hydra genome of genes homologous to genes in other genetically well studied species that have been demonstrated to play key roles in these DNA repair pathways.
John Stewart has become a major recurring character in the Green Lantern mythos within the DC Universe. He became the primary character of Green Lantern vol. 2 from issues #182 through #200, when Hal Jordan relinquished his place in the Green Lantern Corps (1984–1986). He continued to star in the book when the title changed to The Green Lantern Corps from issue #201 to #224 (1986–1988). He would continue to make key appearances in Action Comics Weekly after The Green Lantern Corps' cancellation (1988). He starred in the comic Green Lantern: Mosaic, which DC spun out of Green Lantern vol. 3, with a four-part storyline titled "Mosaic" (issues #14–17). DC published 18 issues of the ongoing Green Lantern: Mosaic title between June 1992 and November 1993. In 2011, John Stewart starred in the New 52 relaunch of Green Lantern Corps alongside Guy Gardner, and became the sole lead character of the title from 2013 until the series' conclusion in 2015. Green Lantern Corps was replaced by Green Lantern: The Lost Army, which also stars John Stewart as the lead. In November 2022, it was announced, as a part of the Dawn of DC relaunch, Stewart would star in a new miniseries entitled Green Lantern: War Journal, written by Phillip Kennedy Johnson and illustrated by Osvaldo Montos.
The Russian Armed Forces use a hybrid system consisting of conscription and volunteer service. All male Russian citizens are required to register for conscription at the age of 17, and all men between the ages of 18 and 27 are required to perform twelve months of military service. The service term was originally two years before being reduced to eighteen months in March 2007 and to one year in January 2008. In December 2022 the maximum age of conscription was increased to 30, and it was proposed to restore the original service term of two years. The mandatory retirement age for most ranks of the military is 65, except for colonel generals or admirals and above, for whom it is 70. According to the Ministry of Defence, the armed forces need to maintain a mobilisation reserve to have manning resources capable of reinforcing the permanent readiness forces if they cannot deter or suppress an armed conflict on their own. The authorised strength of the armed forces is specified by decree of the President of Russia. The armed forces were reduced from the Soviet-era strength of 2.7 million to 2.1 million as of 1994. In 1997, there were 1.6 million personnel, and this was further reduced to about 1 million as of 2000. The 2008 reform reduced officer billets in the armed forces to 220,000, and set a goal of recruiting 425,000 professional contract soldiers by 2017. There were 270,000 conscripts serving each year.
After the prey has been digested, the cone snail will regurgitate any indigestible material, such as spines and scales, along with the harpoon. There is always a radular tooth in the radular sac. A tooth may also be used in self-defense when the snail feels threatened. The harpoon attack of the species Conus catus has been found to be one of the fastest complete movements recorded in animals, with a maximum speed of 90 km/h (56 mph), an acceleration of 400,000 m/s2, and a deceleration of 700,000 m/s2. The speed of other animals such as the peacock mantis shrimp and the trap-jaw ant was measured at the free end of a fixed appendage, while the speed of the harpoon was measured from its base and traveling inside the proboscis. The reason for this speed relies in hydrostatic pressure by the fluid inside the proboscis which propels the harpoon inside until it is almost completely out. A sphincter acts as a valve to keep fluid in the proximal half and in the distal half a constriction of ephitelial tissue together with a thicker harpoon base helps to build up hydrostatic pressure when the sphincter opens. The deceleration may help release the venom from the harpoon.
Sources: en.wikipedia.org
Cold storage slows the chemical degradation reactions that occur in solution. Lyophilized powder is more stable than reconstituted liquid and tolerates longer storage periods. Repeated temperature cycling should still be avoided because it can drive aggregation and loss of material.
Mass spectrometry is the standard confirmation of molecular mass and acetylation state. Chromatography establishes purity but does not identify the molecule on its own. The two techniques are normally applied together during verification.
No, because the reported value reflects the detection method and wavelength used, which vary between laboratories. A number stated without method details cannot be compared directly with another supplier's figure. Requesting the chromatogram and the method conditions is a common way to interpret it.
It is a 28-residue synthetic peptide studied as an immune-modulating agent and approved as a drug in some countries. The sequence matches a naturally occurring fragment isolated from thymus tissue. It is not a hormone in the endocrine sense.